Updated Monday, 12/14. Six IPOs and five SPACs are scheduled to raise $2.8 billion in the week ahead as the IPO market starts to slow down before the holidays. Bargain e-commerce platform Wish (WISH) plans to raise $1.1...read more
In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals (OLMA), which soared 158% on its first day. New filings continued to pour in, priming the IPO...read more
Olema Pharmaceuticals, a Phase 1 biotech developing a targeted oral therapy for ER+/HER2- breast cancer, raised $209 million by offering 11 million shares at $19, above the range of $16 to $18. The company offered 1 million more shares than anticipated. At...read more
Olema Pharmaceuticals, a clinical-stage biotech developing therapies for women's cancers, announced terms for its IPO on Monday.
The San Francisco, CA-based company plans to raise $170 million by offering 10 million shares at a price range of $16 to $18. At...read more
US IPO Week Ahead: The IPO market makes a holiday WISH in a 6 IPO week
Updated Monday, 12/14. Six IPOs and five SPACs are scheduled to raise $2.8 billion in the week ahead as the IPO market starts to slow down before the holidays. Bargain e-commerce platform Wish (WISH) plans to raise $1.1...read more
US IPO Weekly Recap: Breast cancer biotech pops 158% in a 6 IPO week
In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals (OLMA), which soared 158% on its first day. New filings continued to pour in, priming the IPO...read more
Breast cancer biotech Olema Pharmaceuticals prices upsized IPO above the range at $19
Olema Pharmaceuticals, a Phase 1 biotech developing a targeted oral therapy for ER+/HER2- breast cancer, raised $209 million by offering 11 million shares at $19, above the range of $16 to $18. The company offered 1 million more shares than anticipated. At...read more
Women's cancer biotech Olema Pharmaceuticals sets terms for $170 million IPO
Olema Pharmaceuticals, a clinical-stage biotech developing therapies for women's cancers, announced terms for its IPO on Monday. The San Francisco, CA-based company plans to raise $170 million by offering 10 million shares at a price range of $16 to $18. At...read more